Mirum Pharmaceuticals, Inc. - common stock (NQ:MIRM)
119.04
-3.09
(-2.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 601,199 |
| Open | 120.18 |
| Bid (Size) | 118.92 (800) |
| Ask (Size) | 119.18 (100) |
| Prev. Close | 122.13 |
| Today's Range | 117.18 - 120.89 |
| 52wk Range | 50.25 - 130.00 |
| Shares Outstanding | 38,297,975 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Mirum Pharma: A Rare Disease Growth Story to Watch ↗
May 20, 2026
Mirum (MIRM) Q1 2026 Earnings Call Transcript ↗
May 06, 2026
Mirum (MIRM) Q2 2025 Earnings Call Transcript ↗
April 01, 2026
Mirum Pharma (MIRM) Earnings Call Transcript ↗
April 01, 2026
Frequently Asked Questions
Is Mirum Pharmaceuticals, Inc. - common stock publicly traded?
Yes, Mirum Pharmaceuticals, Inc. - common stock is publicly traded.
What exchange does Mirum Pharmaceuticals, Inc. - common stock trade on?
Mirum Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mirum Pharmaceuticals, Inc. - common stock?
The ticker symbol for Mirum Pharmaceuticals, Inc. - common stock is MIRM on the Nasdaq Stock Market
What is the current price of Mirum Pharmaceuticals, Inc. - common stock?
The current price of Mirum Pharmaceuticals, Inc. - common stock is 119.04
When was Mirum Pharmaceuticals, Inc. - common stock last traded?
The last trade of Mirum Pharmaceuticals, Inc. - common stock was at 07/13/26 04:00 PM ET
What is the market capitalization of Mirum Pharmaceuticals, Inc. - common stock?
The market capitalization of Mirum Pharmaceuticals, Inc. - common stock is 4.56B
How many shares of Mirum Pharmaceuticals, Inc. - common stock are outstanding?
Mirum Pharmaceuticals, Inc. - common stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube